LOURDES MENDOZA: Open Payments
NPI 1851717813 · LAS VEGAS, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$351 in 12 payments from 7 companies in 2025. Trend: 2023 $95 · 2024 $442 · 2025 $351
Food & beverage: $351
| Company | Payments | Amount |
|---|---|---|
| Astellas Pharma US Inc | 1 | $125 |
| Novo Nordisk Inc | 3 | $70 |
| Intra-Sana Laboratories | 3 | $66 |
| AstraZeneca Pharmaceuticals LP | 2 | $38 |
| Lilly USA, LLC | 1 | $22 |
| Dexcom, Inc. | 1 | $16 |
| GlaxoSmithKline, LLC. | 1 | $15 |
Products named: Veozah, Wegovy, RELTONE 200 MG, AIRSUPRA, MOUNJARO, Dexcom G6 Transmitter, SHINGRIX.
Industry payments across NV — which companies pay providers there.
